SLC39A13
Basic information
Region (hg38): 11:47407132-47416496
Links
Phenotypes
GenCC
Source:
- spondyloepimetaphyseal dysplasia-abnormal dentition syndrome (Definitive), mode of inheritance: AR
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (Definitive), mode of inheritance: AR
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (Supportive), mode of inheritance: AR
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ehlers-Danlos syndrome, spondylodysplastic type, 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dermatologic; Musculoskeletal | 18985159; 18513683 |
ClinVar
This is a list of variants' phenotypes submitted to
- Ehlers-Danlos syndrome, spondylocheirodysplastic type (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC39A13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 89 | 94 | ||||
missense | 88 | 94 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 8 | 15 | 1 | 24 | ||
non coding | 53 | 15 | 70 | |||
Total | 1 | 1 | 102 | 145 | 19 |
Variants in SLC39A13
This is a list of pathogenic ClinVar variants found in the SLC39A13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-47408638-G-C | not specified | Likely benign (Oct 23, 2017) | ||
11-47408639-G-T | not specified | Likely benign (Mar 09, 2018) | ||
11-47408641-T-TCGC | Benign (May 30, 2018) | |||
11-47408665-G-A | Ehlers-Danlos syndrome | Uncertain significance (Dec 11, 2020) | ||
11-47408665-G-T | Uncertain significance (May 30, 2017) | |||
11-47408907-T-C | Benign (Jun 23, 2018) | |||
11-47408918-T-C | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Uncertain significance (Jan 22, 2021) | ||
11-47409739-T-G | Benign (Aug 07, 2018) | |||
11-47409752-A-G | Likely benign (Jul 14, 2018) | |||
11-47409959-C-T | Likely benign (Jul 14, 2018) | |||
11-47409978-G-A | Benign (Jun 26, 2018) | |||
11-47410014-G-A | Benign (Aug 12, 2018) | |||
11-47410069-G-T | not specified | Likely benign (Nov 28, 2017) | ||
11-47410071-C-A | not specified | Likely benign (Nov 13, 2017) | ||
11-47410116-G-A | Inborn genetic diseases | Uncertain significance (Mar 15, 2024) | ||
11-47410117-G-T | Ehlers-Danlos syndrome, spondylocheirodysplastic type • Inborn genetic diseases | Uncertain significance (May 03, 2023) | ||
11-47410125-A-G | Ehlers-Danlos syndrome, spondylocheirodysplastic type • Inborn genetic diseases | Uncertain significance (Feb 23, 2023) | ||
11-47410126-T-C | Inborn genetic diseases | Uncertain significance (Feb 07, 2023) | ||
11-47410129-C-T | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Uncertain significance (Aug 04, 2023) | ||
11-47410130-G-A | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Likely benign (Feb 23, 2023) | ||
11-47410132-G-C | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Uncertain significance (May 17, 2021) | ||
11-47410132-G-T | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Uncertain significance (Aug 24, 2021) | ||
11-47410133-C-T | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Likely benign (Dec 24, 2021) | ||
11-47410145-C-T | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Likely benign (Jan 04, 2024) | ||
11-47410149-C-T | Ehlers-Danlos syndrome, spondylocheirodysplastic type | Uncertain significance (Aug 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC39A13 | protein_coding | protein_coding | ENST00000362021 | 9 | 9365 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00251 | 0.984 | 125707 | 0 | 29 | 125736 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.26 | 170 | 223 | 0.763 | 0.0000146 | 2347 |
Missense in Polyphen | 48 | 74.657 | 0.64294 | 851 | ||
Synonymous | -0.275 | 108 | 104 | 1.03 | 0.00000768 | 819 |
Loss of Function | 2.16 | 7 | 16.4 | 0.426 | 8.04e-7 | 181 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000249 | 0.000246 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000224 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000143 | 0.000141 |
Middle Eastern | 0.000224 | 0.000217 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a zinc-influx transporter. {ECO:0000269|PubMed:21917916}.;
- Disease
- DISEASE: Ehlers-Danlos syndrome, spondylodysplastic type, 3 (EDSSPD3) [MIM:612350]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD3 is an autosomal recessive form characterized by a generalized skeletal dysplasia involving mainly the spine and striking clinical abnormalities of the hands, in addition to classic features of Ehlers-Danlos syndrome. Clinical features include postnatal growth retardation, moderate short stature, protuberant eyes with bluish sclerae, hands with finely wrinkled palms, atrophy of the thenar muscles, and tapering fingers. Radiologic features include mild to moderate platyspondyly, mild to moderate osteopenia of the spine, small ileum, flat proximal femoral epiphyses, short, wide femoral necks, and broad metaphyses (elbows, knees, wrists, and interphalangeal joints). {ECO:0000269|PubMed:18513683}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Zinc homeostasis
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 0.656
- rvis_EVS
- 0.98
- rvis_percentile_EVS
- 90.38
Haploinsufficiency Scores
- pHI
- 0.308
- hipred
- N
- hipred_score
- 0.242
- ghis
- 0.419
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.485
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc39a13
- Phenotype
- cellular phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- cellular zinc ion homeostasis;response to zinc ion;connective tissue development;zinc ion transmembrane transport
- Cellular component
- endoplasmic reticulum;Golgi apparatus;integral component of membrane;integral component of Golgi membrane;perinuclear region of cytoplasm
- Molecular function
- zinc ion transmembrane transporter activity;protein binding;protein homodimerization activity